Saladax Biomedical is pioneering the development of novel, fast and
inexpensive immunoassays that will enable routine blood level monitoring
of anti-cancer drugs to become the standard of care in treating cancer patients.
With Personalized Chemotherapy Management (PCM), oncologists will be able to
adjust the administered dose based on each patient’s individual drug level leading
to reduced toxicity, improved outcome and lower cancer-care costs.

Now Available - Analyte Specific Reagents for Busulfan Home Brew Testing.